| Q42105037 | Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. |
| Q41668119 | Amyloid β protein substituent peptides do not interact with the substance P receptor expressed in cultured cells |
| Q41874429 | An ubiquitous modulating function of rabbit tracheal epithelium: degradation of tachykinins |
| Q41593256 | Antibodies to the rat substance P receptor: production and characterization |
| Q35870960 | Attenuation of tachykinin‐induced airflow obstruction and microvascular leakage in immature airways |
| Q35601020 | Bradykinin and asthma |
| Q43565597 | Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse |
| Q69127754 | Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system |
| Q48268125 | Diencephalic neurons producing melanin-concentrating hormone are influenced by local and multiple extra-hypothalamic tachykininergic projections through the neurokinin 3 receptor |
| Q44283515 | Differential modulation of murine lung inflammation by bradykinin B1 and B2 selective receptor antagonists |
| Q45560711 | Disulfiram administration affects substance P-like immunoreactive and monoaminergic neural systems in rodent brain |
| Q31090524 | Evidence for binding of the ectodomain of amyloid precursor protein 695 and activated high molecular weight kininogen |
| Q71532972 | Expression and cellular localization of kininogens in the human kidney |
| Q73310580 | Expression of kininogens in the connective tissue-type mast cells of the rat |
| Q37269943 | Expression of the kallikrein/kinin system in human anterior segment |
| Q33586485 | Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1 beta expression |
| Q48002300 | Identification of a delta isoform of preprotachykinin mRNA in human mononuclear phagocytes and lymphocytes |
| Q38304548 | Identification of an epitope in the substance P receptor important for recognition of the common carboxyl-terminal tachykinin sequence |
| Q68040304 | Immunocytochemical localization of albumin, transferrin, angiotensinogen and kininogens during the initial stages of the rat liver differentiation |
| Q67701800 | Immunocytochemical localization of neuromedin K (neurokinin B) in rat spinal ganglia and cord |
| Q42489327 | Inflammatory mediators release calcitonin gene-related peptide from dorsal root ganglion neurons of the rat. |
| Q30802188 | Investigation of substance P transport across the blood-brain barrier |
| Q28305731 | Isolation and characterisation of the human lung NK-1 receptor cDNA |
| Q36697539 | Molecular Characterization of the Three Tachykinin Receptors |
| Q35877504 | Molecular Cloning of a Novel Bradykinin-Related Peptide from the Skin of Indian Bronzed Frog Hylarana Temporalis |
| Q36825080 | Molecular analysis of the differential hepatic expression of rat kininogen family genes |
| Q69119773 | Molecular characterization of rat substance K receptor and its mRNAs |
| Q67674156 | Molecular dynamics simulation provides a possible structure for substance P-like peptides in aqueous solution |
| Q72022673 | Neurochemical characterization of preprotachykinin B(50–79) immunoreactivity in the rat |
| Q48343700 | Neurokinin B peptide-2 neurons project from the hypothalamus to the thoracolumbar spinal cord of the rat |
| Q34086928 | Neurokinin-1 receptor (NK1-R) expression in the brains of SIV-infected rhesus macaques: implications for substance P in NK1-R immune cell trafficking into the CNS |
| Q33830293 | Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation |
| Q42706659 | Nitric oxide is a mediator of tachykinin NK3 receptor-induced relaxation in rat mesenteric artery |
| Q28286127 | Opinion: NK3 receptor antagonists: the next generation of antipsychotics? |
| Q28204105 | Peripheral tachykinin receptors as targets for new drugs |
| Q57951263 | Pharmacological profile of hemokinin 1: a novel member of the tachykinin family |
| Q53863667 | Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain |
| Q52173558 | Postnatal development of NK1, NK2, and NK3 neurokinin receptors expression in the rat retina. |
| Q48391745 | Preprotachykinin a gene expression in distinct hypothalamic and brain stem regions of the rat is affected by a chronic osmotic stimulus: A combined immunohistochemical and in situ hybridization histochemistry study |
| Q73264329 | Quantification of substance P mRNA in human mononuclear phagocytes and lymphocytes using a mimic-based RT-PCR |
| Q39625422 | Quantification of substance p mRNA in human immune cells by real-time reverse transcriptase PCR assay |
| Q40437278 | Real-time reverse transcription-PCR quantitation of substance P receptor (NK-1R) mRNA. |
| Q45631931 | Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries |
| Q44215164 | Regional distribution of neuropeptide γ and other tachykinin peptides derived from the substance P gene in the rat |
| Q45238582 | Role of central tachykinin peptides in cardiovascular regulation in rats |
| Q42458136 | Role of tachykinins in the regulation of the hypothalamo-pituitary-adrenal axis |
| Q40940881 | Spinal cord tachykinins in the micturition reflex. |
| Q35228321 | Structure, Functions, and Mechanisms of Substance P Receptor Action |
| Q39285392 | Substance P Regulation in Epilepsy |
| Q40765448 | Substance P enhances HIV-1 replication in latently infected human immune cells |
| Q41810128 | Substance P increases lymphocyte traffic and lymph flow through peripheral lymph nodes of sheep |
| Q41724189 | Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide |
| Q48930836 | Substance P-like immunoreactive nerve fibers in the pars distalis of the anterior pituitary in the dog |
| Q30360691 | Synaptic control of motoneuronal excitability. |
| Q72085540 | Synthesis, biological activity, and conformational analysis of [pGlu6, N‐MePhe8, Aib9] substance P (6–11): A selective agonist for the NK‐3 receptor |
| Q41491263 | Tachykinins in the gut. Part I. Expression, release and motor function |
| Q57482446 | The Orthoester Johnson-Claisen Rearrangement in the Synthesis of Bioactive Molecules, Natural Products, and Synthetic Intermediates - Recent Advances |
| Q63608674 | The common C-terminal sequences of substance P and neurokinin A contact the same region of the NK-1 receptor |
| Q67707608 | The effect of selective serotonergic neurotoxin treatment on tachykinin levels in the rat ventral spinal cord |
| Q34128078 | The human kininogen gene (KNG) mapped to chromosome 3q26-qter by analysis of somatic cell hybrids using the polymerase chain reaction |
| Q73426216 | The involvement of tachykinin NK2 and NK3 receptors in central sensitization of a spinal withdrawal reflex in the decerebrated, spinalized rabbit |
| Q47436111 | The kallikrein-kinin system in the rat hypothalamus. Immunohistochemical localization of high molecular weight kininogen and T kininogen in different neuronal systems |
| Q28209341 | The primary structure and gene organization of human substance P and neuromedin K receptors |
| Q24537743 | Three-dimensional structure of the mammalian tachykinin peptide neurokinin A bound to lipid micelles |
| Q37662948 | gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors |